Retifanlimab, CAS 2079108-44-2

Product Description: Retifanlimab is an anti-programmed cell death protein 1 (anti-PD-1) monoclonal antibody (mAb). Retifanlimab can be used for the research of gastroesophageal adenocarcinoma (GEA)[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]D V T Catenacci, et al. Margetuximab with retifanlimab as first-line therapy in HER2+/PD-L1+ unresectable or metastatic gastroesophageal adenocarcinoma: MAHOGANY cohort A. ESMO Open. 2022 Oct;7(5):100563.

CAS Number: 2079108-44-2

Molecular Weight: N/A

Compound Purity: 96.84

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: PD-1/PD-L1

• Artikelnummer: MEXHY-P99941-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99941-1
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated